AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

about

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms.Pharmacological treatments for alleviating agitation in dementia: A systematic review and network meta-analysis.

P2860

Q42655602-36243D31-9499-4F99-974E-1D20EB65C4BF Q53279360-E35C5F18-1459-40B1-AD78-17DFD5F4E51D

P2860

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

Item

http://www.wikidata.org/entity/Q39034436

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

@en

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

@nl

type

Item

label

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

@en

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

@nl

prefLabel

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

@en

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

@nl

P1476

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

@en

P2093

George T Grossberg

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's disease

Quinine and quinidine

Nonpharmacologic management of behavioral symptoms in dementia

The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan

Antitussive activity of sigma-1 receptor agonists in the guinea-pig

Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use

Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel

Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs

A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder

P304

121-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2017.1267726

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ricardo P Garay

P577

2016-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27936965

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

about

P2860

P2860

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921